先天性及发育性白内障的基因组诊断:基因Panel与全基因组测序的比较
该回顾性研究纳入119例接受基因检测的先天性白内障患者,其中76例使用靶向基因Panel(2016-2021年),43例使用全基因组测序(WGS,2021-2025年)。WGS较Panel将诊断率提高10%,主要归因于检测到Panel遗漏的变异;总体分子诊断率为42%,非综合征型达51.6%。
要点
- WGS较基因Panel将先天性白内障的诊断率提高10%。
- 总体分子诊断率为42%,非综合征型白内障中达51.6%。
- 非综合征型与综合征型白内障分别占52.1%和47.8%,提示多系统受累常见。
核心结论
- WGS较基因Panel能更有效地为先天性白内障建立分子诊断,因其可检测更多类型的致病变异。
- 较高的综合征型占比使得明确分子诊断对预后、生殖咨询和后续管理尤为关键。
研究设计与样本
- 回顾性研究纳入北泰晤士基因组实验室中心连续119例因先天性白内障接受基因检测的患者。
- 76例(64%)使用靶向基因Panel(2016-2021年),43例(36%)使用WGS(2021-2025年),复杂病例经多学科团队会议讨论。
主要发现
- 非综合征型(孤立性或更广泛眼部异常)与综合征型白内障分别占52.1%和47.8%。
- WGS较基因Panel将诊断率提高10%,主要通过检测Panel方法遗漏的变异实现。
- 总体分子诊断率为42%,非综合征型中诊断率更高,达51.6%。
关键数值与推荐
- 总体分子诊断率42%,非综合征型51.6%,综合征型与非综合征型占比分别为47.8%和52.1%。
- WGS较基因Panel诊断率提高10%。
临床怎么用
- 对先天性白内障患者,WGS可作为优于基因Panel的分子诊断工具,尤其适用于Panel阴性或复杂病例。
- 分子诊断结果应结合多学科团队会议解读,以指导预后判断、生殖咨询及综合征相关监测。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Congenital cataracts are a leading cause of childhood blindness, with clinical impact due both to visual impairment and associated systemic disorders. They exhibit clinical and genetic heterogeneity, with pathogenic variants identified in more than 100 genes complicating genotype-phenotype correlation. Accurate molecular diagnosis is essential for prognosis, reproductive counseling, and tailored surveillance and management. Whole genome sequencing (WGS) offers advantages over gene panels by detecting a broader spectrum of variants, including copy number changes, structural rearrangements, cryptic variants, and those in repetitive regions, thereby improving diagnostic yield, especially when interpreted through multidisciplinary team meetings (MDTMs). METHODS: A retrospective review was performed of 119 consecutive patients undergoing genetic testing for congenital cataracts in the North Thames Genomic Laboratory Hub. Genetic analysis was performed using either targeted gene panels in 76 probands (64%) (2016-2021) or WGS in 43 (36%) (2021-2025). Clinical data were extracted to classify cases as syndromic or nonsyndromic and assess diagnostic outcomes, with complex cases discussed at MDTMs. RESULTS: Nonsyndromic (isolated or wider ocular) and syndromic cataracts accounted for 52.1% and 47.8% of cases, respectively, consistent with previous literature describing frequent multisystem involvement. WGS increased diagnostic yield by 10% compared with gene panels, primarily through detection of variants missed by panel-based approaches. Overall molecular diagnosis was 42%, with higher rates achieved in nonsyndromic forms (51.6%). CONCLUSION: WGS appears more effective for establishing a diagnosis in congenital cataracts than gene panels, because of its ability to detect diverse pathogenic variants. This is critical for provision of prognosis, reproductive counseling, and further management, especially given the high rate of associated syndromic conditions. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
引用
- Lloyd IC, Marlowe S, Piergentili M, et al. Genomic Approaches to Diagnosis in Congenital and Developmental Cataract: Comparison of Panel Versus Whole Genome Sequencing, Diagnostic Yield, Variant Spectrum, Genotype-Phenotype Correlations, and Implications for Counseling. Am J Ophthalmol. 2026. PMID: 42013947. doi:10.1016/j.ajo.2026.03.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。